Obstructive sleep apnea (OSA) is a relatively common disorder that is characterized by repetitive episodes of upper-airway obstruction that occur during sleep and cause repetitive episodes of oxygen desaturation of arterial blood (hypoxia). Chronically, OSA syndrome can result in a number of serous cardiovascular problems including systemic arterial hypertension. There is evidence that the OSA-induced hypertension is neurogenic, that it emanates from the oxygen chemoreceptor cells in the carotid body, and involves the catecholaminergic cells within the peripheral sympathetic nervous system and adrenal medulla. This application proposes that intermittent hypoxia stimulates gene expression in these tissues, and that this may be involved in the pathogenesis of hypertension associated with OSA. This is supported by the previous finding that brief periods (<1hr) of sustained hypoxia stimulates expression of several genes in the oxygen-sensitive type 1 cells of the carotid body, including tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamine synthesis. Enhanced catecholamine biosynthesis in the sympathetic nervous system is a potential mechanism for hypertension. The present research will test the hypothesis that very brief episodes (20 sec) of re-occurring hypoxia are sufficient to increase gene expression in the carotid body, superior cervical ganglion, and the adrenal gland. It is hypothesized that intermittent hypoxia regulates gene expression in these tissues and results in the OSA-induced hypertension.
Specific Aim 1 will focus on the characterizing the effects of intermittent hypoxia on a known hypoxia- regulated gene that has been implicated in hypertension, namely TH and some of its known transcriptional regulators, including c-fos, junB, and CREB.
This aim will also test the hypothesis that gene expression induced by intermittent hypoxia in the superior cervical ganglion and adrenal gland requires synaptic input that originates in the carotid body. It is further hypothesized that coordinate regulation of many genes and proteins mediates the cellular response to such a complex stimulus as intermittent hypoxia. This possibility will be explored in Specific Aim 2, which will focus on identifying the gene and protein expression pattern in the carotid body, superior cervical ganglion and adrenal gland using unique cDNA libraries and high-throughout genomics (cDNA microarray) and proteomics (2-D protein gels and mass spectrometer) analysis. The findings from this study may provide new insight concerning the role of intermittent hypoxia on regulation of gene expression and possible targets for mediating the pathogenesis of OSA-induced hypertension.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL066312-04
Application #
6653109
Study Section
Special Emphasis Panel (ZHL1-CSR-H (S1))
Program Officer
Twery, Michael
Project Start
2000-09-30
Project End
2004-08-31
Budget Start
2003-09-01
Budget End
2004-08-31
Support Year
4
Fiscal Year
2003
Total Cost
$267,750
Indirect Cost
Name
University of Cincinnati
Department
Physiology
Type
Schools of Medicine
DUNS #
041064767
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Ignacak, M L; Harbaugh, S V; Dayyat, E et al. (2009) Intermittent hypoxia regulates RNA polymerase II in hippocampus and prefrontal cortex. Neuroscience 158:1436-45
Haffey, Wendy D; Mikhaylova, Olga; Meller, Jarek et al. (2009) iTRAQ proteomic identification of pVHL-dependent and -independent targets of Egln1 prolyl hydroxylase knockdown in renal carcinoma cells. Adv Enzyme Regul 49:121-32
Mikhaylova, Olga; Ignacak, Monika L; Barankiewicz, Teresa J et al. (2008) The von Hippel-Lindau tumor suppressor protein and Egl-9-Type proline hydroxylases regulate the large subunit of RNA polymerase II in response to oxidative stress. Mol Cell Biol 28:2701-17
Hui, Anna S; Bauer, Amy L; Striet, Justin B et al. (2006) Calcium signaling stimulates translation of HIF-alpha during hypoxia. FASEB J 20:466-75
Zakrzewska, Adriana; Schnell, Phillip O; Striet, Justin B et al. (2005) Hypoxia-activated metabolic pathway stimulates phosphorylation of p300 and CBP in oxygen-sensitive cells. J Neurochem 94:1288-96
Lu, Gang; Seta, Karen A; Millhorn, David E (2005) Novel role for cyclin-dependent kinase 2 in neuregulin-induced acetylcholine receptor epsilon subunit expression in differentiated myotubes. J Biol Chem 280:21731-8
Seta, Karen A; Ferguson, Tsuneo K; Millhorn, David E (2004) Discovery of oxygen-responsive genes in pheochromocytoma cells. Methods Enzymol 381:449-64
Seta, Karen A; Millhorn, David E (2004) Functional genomics approach to hypoxia signaling. J Appl Physiol 96:765-73
Czyzyk-Krzeska, Maria F; Meller, Jaroslaw (2004) von Hippel-Lindau tumor suppressor: not only HIF's executioner. Trends Mol Med 10:146-9
Schnell, Phillip O; Ignacak, Monika L; Bauer, Amy L et al. (2003) Regulation of tyrosine hydroxylase promoter activity by the von Hippel-Lindau tumor suppressor protein and hypoxia-inducible transcription factors. J Neurochem 85:483-91

Showing the most recent 10 out of 17 publications